{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:12:48Z","timestamp":1792174368406,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijantimicag.2020.105941","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:13:52Z","timestamp":1583986432000},"page":"105941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic\/pharmacodynamic modelling from in vitro data"],"prefix":"10.1016","volume":"55","author":[{"given":"Chenyan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-5394","authenticated-orcid":false,"given":"Pikkei","family":"Wistrand-Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Lagerb\u00e4ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-9849","authenticated-orcid":false,"given":"Thomas","family":"T\u00e4ngd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet I.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-679X","authenticated-orcid":false,"given":"Lena E.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.105941_bib0001","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2018.1522249","article-title":"Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control","volume":"16","author":"Bassetti","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0002","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/joim.12342","article-title":"Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control","volume":"277","author":"T\u00e4ngd\u00e9n","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0003","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/phar.1537","article-title":"Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use","volume":"35","author":"Bergen","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2020.03.007","article-title":"Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemaseproducing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments","author":"Wistrand-Yuen","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0006","series-title":"Committee for Medicinal Products for Human Use (CHMP). Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antimicrobial medicinal products.","author":"European Medicines Agency (EMA)","year":"2016"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0007","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/AAC.01286-10","article-title":"Predicting in vitro antibacterial efficacy across experimental designs with a semimechanistic pharmacokinetic\u2013pharmacodynamic model","volume":"55","author":"Nielsen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0008","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cmi.2017.11.023","article-title":"Semi-mechanistic pharmacokinetic\u2013pharmacodynamic modelling of antibiotic drug combinations","volume":"24","author":"Brill","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0009","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/jac\/dkv488","article-title":"Dynamic interaction of colistin and meropenem on a WT and a resistant strain of Pseudomonas aeruginosa as quantified in a PK\/PD model","volume":"71","author":"Mohamed","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0010","first-page":"61","article-title":"Colistin is extensively lost during standard in vitro experimental conditions","author":"Karvanen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0011","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.8.5.532","article-title":"Pharmacokinetics of minocycline in renal failure","volume":"8","author":"Welling","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0012","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/cid\/cit334","article-title":"Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens","volume":"57","author":"Sandri","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0013","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 9.0, 2019.","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2019"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0014","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jpba.2008.12.016","article-title":"Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC\/MS\/MS","volume":"49","author":"Jansson","year":"2009","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00604-06","article-title":"Semimechanistic pharmacokinetic\/pharmacodynamic model for assessment of activity of antibacterial agents from time\u2013kill curve experiments","volume":"51","author":"Nielsen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0017","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0018","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/s41467-017-01929-y","article-title":"A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions","volume":"8","author":"Wicha","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0019","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","article-title":"Likelihood based approaches to handling data below the quantification limit using NONMEM VI","volume":"35","author":"Ahn","year":"2008","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF02353466","article-title":"Three new residual error models for population PK\/PD analyses","volume":"23","author":"Karlsson","year":"1995","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0021","unstructured":"Karlsson MO, Holford N.A tutorial on visual predictive checks. In: Abstracts of the Annual Meeting of the Population Approach Group in Europe; 18\u201320 June 2008; Marseille, France. PAGE; 2008."},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0022","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.xphs.2017.09.006","article-title":"Impact of experimental variables on the protein binding of tigecycline in human plasma as determined by ultrafiltration","volume":"107","author":"Dorn","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0023","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/jac\/dkx039","article-title":"The complexity of minocycline serum protein binding","volume":"72","author":"Zhou","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0024","first-page":"341","article-title":"Tsuji BT; International Society of Anti-Infective Pharmacology (ISAP)","volume":"122","author":"Nation","year":"2018","journal-title":"Concentration-dependent plasma protein binding: expect the unexpected. Eur J Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0026","series-title":"MINOCIN\u24c7 (minocycline for injection)","author":"Melinta Therapeutics","year":"2019"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0027","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/aws072","article-title":"Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury","volume":"135","author":"Casha","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0028","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.04110-14","article-title":"Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii","volume":"59","author":"Bowers","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0029","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/infdis\/jiu237","article-title":"Interaction of drug- and granulocyte-mediated killing of Pseudomonas aeruginosa in a murine pneumonia model","volume":"210","author":"Drusano","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40121-017-0153-2","article-title":"Minocycline for the treatment of multidrug and extensively drug-resistant A. baumannii: a review","volume":"6","author":"Lashinsky","year":"2017","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0031","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00073-17","article-title":"In vitro assessment of combined polymyxin B and minocycline therapy against Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae","volume":"61","author":"Huang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0032","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1093\/jac\/dkx241","article-title":"Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology","volume":"72","author":"Brennan-Krohn","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0033","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41467-018-02875-z","article-title":"Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics","volume":"9","author":"MacNair","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0034","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01165-17","article-title":"A retrospective cohort analysis shows that coadministration of minocycline with colistin in critically ill patients is associated with reduced frequency of acute renal failure","volume":"62","author":"Lodise","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0035","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/jac\/dkx037","article-title":"Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress","volume":"72","author":"Dai","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0036","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s11095-016-1856-x","article-title":"Simulation-based evaluation of PK\/PD indices for meropenem across patient groups and experimental designs","volume":"33","author":"Kristoffersson","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0037","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jac\/dkw057","article-title":"A pharmacokinetic\u2013pharmacodynamic (PKPD) model based on in vitro time\u2013kill data predicts the in vivo PK\/PD index of colistin","volume":"71","author":"Khan","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0038","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10928-016-9486-9","article-title":"A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection","volume":"44","author":"Sadiq","year":"2017","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ijantimicag.2020.105941_bib0039","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/jac\/dkx269","article-title":"Can a pharmacokinetic\/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data","volume":"72","author":"Nielsen","year":"2017","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920300911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:36:56Z","timestamp":1760377016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920300911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0924857920300911"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105941","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic\/pharmacodynamic modelling from in vitro data","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105941"}}